1-2 of 2
Katja Fücker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM

Steven M Haffner, MD, Markolf Hanefeld, MD, Sabine Fischer, MD, Katja Fuçker, DIPL CHEM, Wolfgang Leonhardt, PHD
Journal: Diabetes Care
Diabetes Care 1997;20(9):1430–1434
https://doi.org/10.2337/diacare.20.9.1430
Published: 01 September 1997
View article titled, Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM
Open the PDF for Glibenclamide, but Not Acarbose, Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM in another window
Journal Articles

Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone

Markolf Hanefeld, DSc, Sabine Fischer, DSc, Jan Schulze, DSc, Manfred Spengler, PhD, Manfred Wargenau, PhD, Karl Schollberg, PhD, Katja Fücker, DC
Journal: Diabetes Care
Diabetes Care 1991;14(8):732–737
https://doi.org/10.2337/diacare.14.8.732
Published: 01 August 1991
View article titled, Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone
Open the PDF for Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone in another window